483 Roundup: FDA Cites Six Device Firms for GMP Issues

The GMP Letter
The FDA hit six U.S. devicemakers with 483s for problems agency investigators observed in facility inspections including inadequate risk procedures, labeling and complaint handling.

To View This Article:


Subscribe To The GMP Letter

Buy This Article Now

Add this article to your cart for $200.00